An Observational study to determine the serum levetiracetam drug level in pregnant women with epileptic fits correlating with mother and child outcome
Not Applicable
- Conditions
- Health Condition 1: G404- Other generalized epilepsy and epileptic syndromes
- Registration Number
- CTRI/2020/08/027367
- Lead Sponsor
- PGIMER
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Pregnant women with confirmed diagnosis of epilepsy and on stable dose of
levetiracetam throughout gestation period
2. Subject on a stable dose of one or two antiepileptic drugs during baseline.
3. Participants willing to provide written informed consent.
Exclusion Criteria
Patients with unstable medical conditions like renal and hepatic insufficiency and history of neuropsychiatric disorder.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method